Reinaldo M. Diaz
Managing Director - Investments & Business Development, US
Mr. Diaz is Managing Director of Auven Therapeutics with responsibility for investments and business development in the US. He has over 30 years of experience in the biopharmaceutical industry. Prior to joining Auven Therapeutics, he was a Managing Member and Co-Founder of D&A Capital Management, LLC (D&A Capital), a firm focused on asset management and providing advisory services to biopharmaceutical companies. D&A Capital, through affiliated entities, managed the Delta Opportunity Funds (Delta), a group of hedge funds with over $100 million in assets under management. D&A Capital, under the guidance of Mr. Diaz and his co-founder, pursued a flexible investment strategy focused on providing attractive returns from investments in the biopharmaceutical sector while mitigating volatility. In addition, D&A Capital structured and acted as private placement agent for transactions that provided over $230 million for leading companies in the biopharmaceutical sector. Prior to funding D&A Capital, Mr. Diaz was Managing Director and Head of the Healthcare group at Schroder Wertheim & Co., Inc. In that capacity, he was responsible for establishing and expanding Schroder Wertheim’s investment banking presence in the healthcare industry. Mr. Diaz started his career at PaineWebber, Inc., where he was a key member of the PaineWebber Healthcare Investment Banking Group and of PaineWebber Development Corporation. He was President of PaineWebber Development Corporation at the time he left. Mr. has a BA degree from Harvard College and an MBA degree from Harvard University.